These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21249466)

  • 1. Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration.
    Poksay KS; Madden DT; Peter AK; Niazi K; Banwait S; Crippen D; Bredesen DE; Rao RV
    J Mol Neurosci; 2011 Jun; 44(2):91-102. PubMed ID: 21249466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
    Kobayashi T; Tanaka K; Inoue K; Kakizuka A
    J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
    Noguchi M; Takata T; Kimura Y; Manno A; Murakami K; Koike M; Ohizumi H; Hori S; Kakizuka A
    J Biol Chem; 2005 Dec; 280(50):41332-41. PubMed ID: 16234241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological consequences of VCP mutations on human striated muscle.
    Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
    Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
    Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
    J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
    Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
    Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
    Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
    Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
    Gitcho MA; Strider J; Carter D; Taylor-Reinwald L; Forman MS; Goate AM; Cairns NJ
    J Biol Chem; 2009 May; 284(18):12384-98. PubMed ID: 19237541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD).
    Lee JJ; Park JK; Jeong J; Jeon H; Yoon JB; Kim EE; Lee KJ
    J Biol Chem; 2013 Mar; 288(10):6998-7011. PubMed ID: 23293021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
    Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
    Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
    Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
    J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
    Manno A; Noguchi M; Fukushi J; Motohashi Y; Kakizuka A
    Genes Cells; 2010 Aug; 15(8):911-22. PubMed ID: 20604808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations.
    Kim NC; Tresse E; Kolaitis RM; Molliex A; Thomas RE; Alami NH; Wang B; Joshi A; Smith RB; Ritson GP; Winborn BJ; Moore J; Lee JY; Yao TP; Pallanck L; Kundu M; Taylor JP
    Neuron; 2013 Apr; 78(1):65-80. PubMed ID: 23498974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation.
    Bersano A; Del Bo R; Lamperti C; Ghezzi S; Fagiolari G; Fortunato F; Ballabio E; Moggio M; Candelise L; Galimberti D; Virgilio R; Lanfranconi S; Torrente Y; Carpo M; Bresolin N; Comi GP; Corti S
    Neurobiol Aging; 2009 May; 30(5):752-8. PubMed ID: 17889967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
    Weihl CC; Pestronk A; Kimonis VE
    Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.